SB236 - Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Kansas - 2023-2024 Regular Session
Introduced byPublic Health and Welfare
Last updated 5 months ago
0 Co-Sponsors
STATUS
Failed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now